Search research articles
Contact Us
Filters
Showing results (341-350 of 414) with videos related to
Page
of 42
Sort By:
JNCI Cancer Spectrum
|
May 2, 2024
A phase I/II study of nintedanib and capecitabine for refractory metastatic colorectal cancer
Patrick M Boland, John M L Ebos, Kristopher Attwood, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Tumor microbiome differences in early-onset versus average-onset pancreatic adenocarcinoma
T Jayakrishnan, N Sangwan, K G Nair, et al.
Genes & Development
|
March 7, 1998
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha
N V Iyer, L E Kotch, F Agani, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 2011
Characterization of two mutations, M287L and Q266I, in the α1 glycine receptor subunit that modify sensitivity to alcohols
Cecilia M Borghese, Yuri A Blednov, Yu Quan, et al.
The Journal of Clinical Investigation
|
March 13, 1999
Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha
A Y Yu, L A Shimoda, N V Iyer, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
April 29, 2006
Management of locoregional stage esophageal cancer: a single center experience
M M Javle, C E Nwogu, K A Donohue, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 6, 2010
Renal atrophy secondary to chemoradiotherapy of abdominal malignancies
Gary Y Yang, Kilian Salerno May, Renuka V Iyer, et al.
The British Journal of Dermatology
|
November 20, 2018
POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families
M Potrony, J A Puig-Butille, M Ribera-Sola, et al.
Journal of Medicinal Chemistry
|
April 6, 2010
Development of a new generation of 4-aminoquinoline antimalarial compounds using predictive pharmacokinetic and toxicology models
Sunetra Ray, Peter B Madrid, Paul Catz, et al.
Pediatric Blood & Cancer
|
October 27, 2009
Adherence to study medication and visits: data from the BABY HUG trial
Courtney D Thornburg, Zora R Rogers, Michael R Jeng, et al.
Page
of 42
Search research articles
Search
Showing results (341-350 of 414) with videos related to
Sort By:
Page
of 42
JNCI Cancer Spectrum
|
May 2, 2024
A phase I/II study of nintedanib and capecitabine for refractory metastatic colorectal cancer
Patrick M Boland, John M L Ebos, Kristopher Attwood, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Tumor microbiome differences in early-onset versus average-onset pancreatic adenocarcinoma
T Jayakrishnan, N Sangwan, K G Nair, et al.
Genes & Development
|
March 7, 1998
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha
N V Iyer, L E Kotch, F Agani, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 2011
Characterization of two mutations, M287L and Q266I, in the α1 glycine receptor subunit that modify sensitivity to alcohols
Cecilia M Borghese, Yuri A Blednov, Yu Quan, et al.
The Journal of Clinical Investigation
|
March 13, 1999
Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha
A Y Yu, L A Shimoda, N V Iyer, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
April 29, 2006
Management of locoregional stage esophageal cancer: a single center experience
M M Javle, C E Nwogu, K A Donohue, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 6, 2010
Renal atrophy secondary to chemoradiotherapy of abdominal malignancies
Gary Y Yang, Kilian Salerno May, Renuka V Iyer, et al.
The British Journal of Dermatology
|
November 20, 2018
POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families
M Potrony, J A Puig-Butille, M Ribera-Sola, et al.
Journal of Medicinal Chemistry
|
April 6, 2010
Development of a new generation of 4-aminoquinoline antimalarial compounds using predictive pharmacokinetic and toxicology models
Sunetra Ray, Peter B Madrid, Paul Catz, et al.
Pediatric Blood & Cancer
|
October 27, 2009
Adherence to study medication and visits: data from the BABY HUG trial
Courtney D Thornburg, Zora R Rogers, Michael R Jeng, et al.
Page
of 42